Home > News Shots > World

By Nidharshana | Sep 11, 2020 11:56 AM

Earlier this week, the clinical human trials of the vaccine developed by the Oxford University and AstraZeneca were paused in several countries. The reason behind this sudden pause was identified to be an adverse side-effect that the vaccine gave a woman.

oxford astrazeneca vaccine trial stopped neurological symptoms

The woman is said to have developed a severe neurological symptom, said a spokesperson for AstraZeneca on Thursday. The participant is expected to have developed transverse myelitis, which is a rare case of inflammation of the spinal cord said Matthew Kent, spokesman.

“We don’t know if it is (transverse myelitis). More tests are being done now as part of the follow-up,” said Kent. He further added that a “standard review process triggered a pause to vaccination to allow review of safety data.” AstraZeneca pointed out that this side-effect could be a coincidence and that such temporary pauses in medical researchers are not unusual. Investigating such unexpected reactions are important, said the spokesperson.

AstraZeneca began recruiting over 30,000 volunteers in the US for testing the vaccine in August. Further, thousands of people from Britain, South Africa, and Brazil were also included in the study. While the study is paused in several countries over this safety concern, the World Health Organisation has said that it is not overly concerned about it and that this is a “wake-up call” to the world about the realities of medical research.

அரசியல், விளையாட்டு, நாட்டுநடப்பு, குற்ற சம்பவங்கள், வர்த்தகம், தொழில்நுட்பம், சினிமா, வாழ்க்கை முறை என பலதரப்பட்ட சுவாரஸ்யமான செய்திகளை தமிழில் படிக்க இங்கு கிளிக் செய்யவும்      



This page contains news relating to various facts and events. The views are generally about current affiars and general topics in diversified areas such as political, international, national, and regional issues, sports, health, travel, lifestyle, technology and business. People having similar interets on the above topics will find this page useful. Oxford astrazeneca vaccine trial stopped neurological symptoms | World News.